DK0869957T3 - 3(2H)-Pyridazinonderivater og farmaceutiske sammensætninger indeholdende disse forbindelser - Google Patents
3(2H)-Pyridazinonderivater og farmaceutiske sammensætninger indeholdende disse forbindelserInfo
- Publication number
- DK0869957T3 DK0869957T3 DK96919967T DK96919967T DK0869957T3 DK 0869957 T3 DK0869957 T3 DK 0869957T3 DK 96919967 T DK96919967 T DK 96919967T DK 96919967 T DK96919967 T DK 96919967T DK 0869957 T3 DK0869957 T3 DK 0869957T3
- Authority
- DK
- Denmark
- Prior art keywords
- compounds
- pharmaceutical compositions
- compositions containing
- pyridazinone
- pyridazinone derivatives
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- AAILEWXSEQLMNI-UHFFFAOYSA-N 1h-pyridazin-6-one Chemical class OC1=CC=CN=N1 AAILEWXSEQLMNI-UHFFFAOYSA-N 0.000 title 1
- FJNRJBQUOQLUNQ-CYBMUJFWSA-N 2-[3-[[(3r)-2,3-dihydro-1,4-benzodioxin-3-yl]methylamino]propyl]pyridazin-3-one Chemical compound O=C1C=CC=NN1CCCNC[C@H]1OC2=CC=CC=C2OC1 FJNRJBQUOQLUNQ-CYBMUJFWSA-N 0.000 abstract 1
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 abstract 1
- 108020004102 alpha-1 Adrenergic Receptor Proteins 0.000 abstract 1
- 108020004101 alpha-2 Adrenergic Receptor Proteins 0.000 abstract 1
- 102000015009 alpha1-adrenergic receptor activity proteins Human genes 0.000 abstract 1
- 102000015006 alpha2-adrenergic receptor activity proteins Human genes 0.000 abstract 1
- 230000003042 antagnostic effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000007858 starting material Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU9501560A HU224067B1 (hu) | 1995-05-29 | 1995-05-29 | 3(2H)-Piridazinon-származékok és e vegyületeket tartalmazó gyógyszerkészítmények |
| PCT/HU1996/000030 WO1996038441A1 (en) | 1995-05-29 | 1996-05-28 | 3(2h)-pyridazinone derivatives and pharmaceutical compositions containing these compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0869957T3 true DK0869957T3 (da) | 2002-07-01 |
Family
ID=10986884
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK96919967T DK0869957T3 (da) | 1995-05-29 | 1996-05-28 | 3(2H)-Pyridazinonderivater og farmaceutiske sammensætninger indeholdende disse forbindelser |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US6194411B1 (ja) |
| EP (1) | EP0869957B1 (ja) |
| JP (2) | JP3857313B2 (ja) |
| KR (1) | KR100408364B1 (ja) |
| AT (1) | ATE214389T1 (ja) |
| AU (1) | AU710265B2 (ja) |
| CA (1) | CA2222724C (ja) |
| DE (1) | DE69619861T2 (ja) |
| DK (1) | DK0869957T3 (ja) |
| ES (1) | ES2175100T3 (ja) |
| HU (1) | HU224067B1 (ja) |
| PT (1) | PT869957E (ja) |
| WO (1) | WO1996038441A1 (ja) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU227237B1 (en) | 2001-09-27 | 2010-12-28 | Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag | Substituted alkylpyridazinone derivatives, process for their preparation, pharmaceutical compositions containing them |
| PA8663501A1 (es) | 2005-02-17 | 2006-11-09 | Wyeth Wyeth | Derivados de indol, benzotiofeno, benzofurano e indeno cicloalquilcondensados |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU195645B (en) * | 1985-10-30 | 1988-06-28 | Gyogyszerkutato Intezet | Process for preparing novel 3(2h)-pyridazinone derivatives and pharmaceutical compositions comprising the same |
-
1995
- 1995-05-29 HU HU9501560A patent/HU224067B1/hu not_active IP Right Cessation
-
1996
- 1996-05-28 US US08/973,584 patent/US6194411B1/en not_active Expired - Fee Related
- 1996-05-28 AT AT96919967T patent/ATE214389T1/de not_active IP Right Cessation
- 1996-05-28 PT PT96919967T patent/PT869957E/pt unknown
- 1996-05-28 DE DE69619861T patent/DE69619861T2/de not_active Expired - Fee Related
- 1996-05-28 ES ES96919967T patent/ES2175100T3/es not_active Expired - Lifetime
- 1996-05-28 KR KR1019970708521A patent/KR100408364B1/ko not_active IP Right Cessation
- 1996-05-28 EP EP96919967A patent/EP0869957B1/en not_active Expired - Lifetime
- 1996-05-28 DK DK96919967T patent/DK0869957T3/da active
- 1996-05-28 AU AU58427/96A patent/AU710265B2/en not_active Ceased
- 1996-05-28 JP JP53631996A patent/JP3857313B2/ja not_active Expired - Fee Related
- 1996-05-28 WO PCT/HU1996/000030 patent/WO1996038441A1/en active IP Right Grant
- 1996-05-28 CA CA002222724A patent/CA2222724C/en not_active Expired - Fee Related
-
2000
- 2000-08-28 US US09/649,077 patent/US6248907B1/en not_active Expired - Fee Related
-
2006
- 2006-06-01 JP JP2006153349A patent/JP2006316064A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| HU9501560D0 (en) | 1995-07-28 |
| ATE214389T1 (de) | 2002-03-15 |
| HUT75104A (en) | 1997-04-28 |
| EP0869957B1 (en) | 2002-03-13 |
| CA2222724A1 (en) | 1996-12-05 |
| US6248907B1 (en) | 2001-06-19 |
| US6194411B1 (en) | 2001-02-27 |
| DE69619861D1 (de) | 2002-04-18 |
| JP2006316064A (ja) | 2006-11-24 |
| JP3857313B2 (ja) | 2006-12-13 |
| JPH11506094A (ja) | 1999-06-02 |
| DE69619861T2 (de) | 2002-09-26 |
| CA2222724C (en) | 2006-05-23 |
| PT869957E (pt) | 2002-09-30 |
| KR19990022042A (ko) | 1999-03-25 |
| AU710265B2 (en) | 1999-09-16 |
| ES2175100T3 (es) | 2002-11-16 |
| KR100408364B1 (ko) | 2004-06-14 |
| WO1996038441A1 (en) | 1996-12-05 |
| EP0869957A2 (en) | 1998-10-14 |
| HU224067B1 (hu) | 2005-05-30 |
| AU5842796A (en) | 1996-12-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG103964A (en) | SUBSTITUTED PYRAZOLS AS p38 KINASE INHIBITORS | |
| TR200103273T2 (tr) | Hemisentetik yöntem ve yeni bileşimler. | |
| AP2001002172A0 (en) | Substituted pyrazoles as p38 kinase inhibitors | |
| DE69719350D1 (de) | 2-pyrimidinamin derivaten und verfahrens zu deren herstellung | |
| EA200200374A1 (ru) | Производные хинолилпропилпиперидина, их получение и содержащие их композиции | |
| BR9916396A (pt) | Herbicidas | |
| DK0870768T3 (da) | Azaindol-ethylaminderivater som nikotinacetylcholinreceptor-bindingsmidler | |
| DK0696281T3 (da) | Hidtil ukendte 5-pyrrolyl-2-pyridylmethylsulfinylbenzimidazolderivater | |
| AU5574799A (en) | Pyridyl ethers and thioethers as ligands for nicotinic acetylcholine receptor and its therapeutic application | |
| MXPA02011370A (es) | Iminoazinas substituidas. | |
| DK0567271T3 (da) | Steroidderivater til behandling af prostatahypertrofi, fremgangsmåde til fremstilling heraf og anvendelser heraf | |
| FI970147A (fi) | Triatsoliyhdisteitä ja niiden käyttö dopamiini-D3-ligandeina | |
| AP2001002191A0 (en) | 3,3- Biarylpiperine and 2,2-biarylmorpholine derivatives. | |
| AP2003002810A0 (en) | 1,4-Disubstituted piperazine derivatives useful as uro-selective a, - adrenoceptor blockers | |
| CA2356985A1 (en) | 5ht1 antagonists for antidepressant therapy | |
| YU76500A (sh) | Hemijska sinzeza morfolinskih derivata | |
| HK1026701A1 (en) | Heterocycles useful in the treatment of benign prostatic hyperplasia and intermediates thereof | |
| AU2084195A (en) | Indole derivative and medicine containing the same | |
| DK0869957T3 (da) | 3(2H)-Pyridazinonderivater og farmaceutiske sammensætninger indeholdende disse forbindelser | |
| DE69906243T2 (de) | 2-Indanmethanolderivate und ihre Verwendung als Riechstoffe | |
| MXPA04002838A (es) | Derivados de alquilaminopiridazinona sustituidos, procedimiento para la preparacion de los mismos y composiciones farmaceuticas que los contienen. | |
| MEP12408A (en) | Acyloxypyrrolidine derivatives and use thereof as ligands of v1b or both v1b and v1a receptors | |
| CA2374643A1 (en) | 1-trifluoromethyl-4-hydroxy-7-piperidinylaminomethylchroman derivatives as substance p antagonists | |
| MY133098A (en) | New nitromethyl ketones, process for preparing them and compositions containing them | |
| RS50305B (sr) | 4-halogenovani 17-metilen steroidi, postupak njihove proizvodnje i farmaceutski sastavi koji sadrže ova jedinjenja |